Johnson & Johnson

J&J enters Medicare drug price negotiation program amid lawsuit Bloomberg Law10:47
Here’s what’s moving the needle in biotech stocks, in the final quarter of a dismal year STAT09:48
Applications open for Johnson & Johnson's second Health equity Innovation challenge PR Newswire (Press Release)09:06
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws… Fortune13:53
Advocates hail Johnson & Johnson decision to allow generic versions of key TB drug The Globe and Mail19:49
Millions of people could live thanks to new access to tuberculosis medication Mother Jones18:18
'Unreliable' experts sink $224M talc award, j&j tells court Law36020:44

Latest News

In the last 15 minutes

Global Women's Digital Health Market 2023-2030: Bayer, Fitbit, Johnson & Johnson, and Eli Lilly and Novartis Drive… GlobeNewswire (Press Release)05:43

In the last 2 hours

Sanofi Clinches Vaccine Deal With J&J to Battle E. Coli BNN Bloomberg04:22

Earlier today

Press Release Biocartis Group NV: Disclosure of transparency notification GlobeNewswire (Press Release)01:09

Yesterday

J&J Patent Move Must be First of Many, says AHF Business Wire (Press Release)19:10 2-Oct-23

Johnson & Johnson drops secondary patents for bedaquiline Center for Infectious Disease Research and Policy15:44 2-Oct-23

Novo Nordisk, Johnson & Johnson, Amgen and Novartis agree to participate in Medicare negotiations ENDPOINTS12:00 2-Oct-23

Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo FiercePharma11:41 2-Oct-23

J&J Enters Medicare Drug Price Negotiation Program Amid Lawsuit Bloomberg Law10:47 2-Oct-23

Here’s what’s moving the needle in biotech stocks, in the final quarter of a dismal year STAT09:48 2-Oct-23

Applications Open for Johnson & Johnson's Second Health Equity Innovation Challenge PR Newswire (Press Release)09:06 2-Oct-23

In the last 7 days

Advocates hail Johnson & Johnson decision to allow generic versions of key TB drug The Globe and Mail19:49 1-Oct-23

Millions of People Could Live Thanks to New Access to Tuberculosis Medication Mother Jones18:18 1-Oct-23

Pharma cos can supply generic Bedaquiline to other countries The Times of India15:06 1-Oct-23

J&J will not enforce patents on key TB drug bedaquiline in low- and middle-income countries The Hindu10:42 1-Oct-23

Africa: Breakthrough Promises Improved Access to TB Treatment Across Africa AllAfrica08:20 1-Oct-23

Africa: U.S. Drug Company Eases Access to Multidrug-Resistant Tuberculosis Treatment AllAfrica07:06 1-Oct-23

Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock? The Motley Fool06:06 1-Oct-23

J&J to not enforce patents on breakthrough TB drug bedaquiline The Hindu Business Line05:40 1-Oct-23

LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns? TipRanks22:34 30-Sep-23

MSF welcomes J&J's decision to not enforce unnecessary patents on key TB drug Doctors Without Borders (Press Release)14:35 30-Sep-23

STAT Plus: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor… STAT14:31 30-Sep-23

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low-… MSF Access Campaign12:36 30-Sep-23

Aid agency urges Johnson & Johnson to improve access to tuberculosis drug Malay Mail21:00 29-Sep-23

Johnson & Johnson Confirms Intent Not to Enforce Patents for SIRTURO® (bedaquiline) for the Treatment of… Johnson & Johnson (Press Release)19:17 29-Sep-23

STAT Plus: Unitaid slams J&J over pricing and patents for a tuberculosis drug STAT14:56 29-Sep-23

Global Cholera Vaccines Market 2023-2028: Key Players Like Merck, Johnson & Johnson and Sanofi are Leading the Way in… GlobeNewswire (Press Release)05:45 29-Sep-23

Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline Reuters04:45 29-Sep-23

J&J doublet beats Tagrisso in first-line lung cancer pharmaphorum04:00 29-Sep-23

Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws… Fortune13:53 28-Sep-23

J&J Sees Talc-Suit Surge After $9 Billion Settlement Tossed BNN Bloomberg12:39 28-Sep-23

J&J Sees Talc-Suit Surge After $9 Billion Bankruptcy Plan Tossed Bloomberg Law11:46 28-Sep-23

J&J’s Rybrevant in Combo with Lazertinib Clears Phase III in NSCLC BioSpace10:09 28-Sep-23

J&J's lung cancer therapy combo succeeds in late-stage study Reuters07:44 28-Sep-23

Global Cancer Pain Market 2023-2028: Eli Lilly & Company and Johnson & Johnson at the Forefront of Personalized Pain… GlobeNewswire (Press Release)05:30 28-Sep-23

Global Medical Lasers Markets and Technology Analysis Report 2023-2028 Featuring Major Players - Nidek, Cynosure, Ziess … GlobeNewswire (Press Release)04:08 28-Sep-23

'Unreliable' Experts Sink $224M Talc Award, J&J Tells Court Law36020:44 27-Sep-23

Kenvue Hires Slate Of Three Agencies For Product PR PRovoke20:32 27-Sep-23

Notable Wednesday Option Activity: JNJ, RIVN, KRTX Nasdaq15:59 27-Sep-23

Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson MarketWatch13:36 27-Sep-23

IBM, J&J Health Care Systems sued over August 2023 data breach HealthLeaders13:23 27-Sep-23

Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall MarketWatch12:15 27-Sep-23

Global LASIK Eye Surgery Devices Market to 2028 with Johnson & Johnson, ZEISS Group, Alcon,… Business Wire (Press Release)12:01 27-Sep-23

Relative Strength Alert For Johnson & Johnson Nasdaq11:54 27-Sep-23

Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks MarketWatch10:54 27-Sep-23

3 Things About Johnson & Johnson That Smart Investors Know The Motley Fool05:40 27-Sep-23

Judge OKs Fees For Talc Lawyers In J&J Unit's First Ch. 11 Law36016:46 26-Sep-23

Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight |… GlobeNewswire (Press Release)13:10 26-Sep-23

Johnson & Johnson Vision Teams Up with Photographer and New York Times Best-Selling Author, Kate T. Parker to Ignite… Johnson & Johnson (Press Release)10:27 26-Sep-23

IBM, Johnson & Johnson Hit With Class Action Over Data Breach Bloomberg Law09:42 26-Sep-23

2 Monster Stocks to Buy Without Any Hesitation The Motley Fool07:47 26-Sep-23

Johnson & Johnson Vision introduces Silk procedure for Myopia correction in India The Times of India05:08 26-Sep-23

JLABS collaborates with EDB to transform Singapore’s Life Science Innovation Ecosystem BioSpectrum Asia04:27 26-Sep-23

In the last month

IBM, J&J Face Class Action Over August Patient Data Breach Law36021:06 25-Sep-23

Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform… AsiaOne19:19 25-Sep-23

Tuberculosis is the latest front in global battle over drug prices The Globe and Mail14:21 25-Sep-23

Johnson & Johnson: The Bull Case Can No Longer Be Ignored Seeking Alpha08:39 23-Sep-23

Protagonist Therapeutics: There Are Reasons Behind Johnson & Johnson's Optimism Seeking Alpha15:41 22-Sep-23

SPLG, JPM, JNJ, MRK: Large Inflows Detected at ETF Nasdaq11:17 22-Sep-23

Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the… PR Newswire (Press Release)10:10 22-Sep-23

Talc Manufacturer’s Removal Motion Denied Joinder; Case Remanded to State Court JD Supra19:37 21-Sep-23

Global Biopharmaceuticals Market Outlook Report 2023-2027 Featuring Johnson & Johnson, Pfizer,… PR Newswire (Press Release)18:51 21-Sep-23

Osteal Therapeutics Closes $23M Series C Financing BioSpace08:35 21-Sep-23

Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based… MSF Access Campaign05:28 21-Sep-23

Azerbaijan: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to… MSF Access Campaign05:28 21-Sep-23

Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based… MSF Access Campaign05:28 21-Sep-23

Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based… MSF Access Campaign05:28 21-Sep-23

Endoscopy Devices Market size to grow by USD 14.04 billion from 2022-2027 | Arthrex Inc.,… PR Newswire (Press Release)05:16 21-Sep-23

Johnson & Johnson Vision unveils SILK laser vision correction procedure in India The Hindu10:33 20-Sep-23

Asia Pacific Facial Care Market 2023-2030: Johnson & Johnson Limited and Kose Corporation: A Closer Look at Diversity… GlobeNewswire (Press Release)08:06 20-Sep-23

Sen. Hawley Grills Top Johnson & Johnson Attorney Over Liability Related to Cancer Claims NTD News22:36 19-Sep-23

J&J Defends Texas Two-Step Talc Gambit To Lawmakers Law36020:33 19-Sep-23

1st Circ. Sides With J&J Subsidiary In Lactaid False Ad Suit Law36019:21 19-Sep-23

'Texas Two-Step' Is Only Path to Talc Claim Payouts, J&J Litigation VP Tells Senate Panel Law.com17:28 19-Sep-23

Senators Press J&J Official on Whether Bankruptcy System Is Being Manipulated The Wall Street Journal16:35 19-Sep-23

Johnson & Johnson Wins Appeal Challenging Lactaid’s Labeling Bloomberg Law16:06 19-Sep-23

AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment Business Wire (Press Release)12:55 19-Sep-23

Hair and Scalp Care Products Market: Getting Back To Growth| Unilever, Johnson & Johnson, Coty Industry Today07:50 19-Sep-23

Impulse Dynamics Announces Leadership Changes GlobeNewswire (Press Release)07:20 19-Sep-23

Kenvue Is Not The Better Johnson & Johnson, Also Not For Dividend Investors Seeking Alpha06:00 19-Sep-23

Johnson & Johnson: A Very Cautious 'Buy' Seeking Alpha17:51 18-Sep-23

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Business Wire (Press Release)16:32 18-Sep-23

Johnson & Johnson unveils new logo and visual identity Creative Review07:40 18-Sep-23

Johnson & Johnson's Reinvention - Is A New Logo Enough? Seeking Alpha07:36 18-Sep-23

Anthos hails win over Xarelto with novel anticoagulant pharmaphorum07:10 18-Sep-23

Johnson & Johnson: Kenvue Spin-Off Unlikely To Drive Market-Beating Returns Seeking Alpha00:59 18-Sep-23

Commission to probe Johnson & Johnson’s TB drug monopoly IOL14:03 17-Sep-23

Competition watchdog probes J&J TB drug pricing Business Day12:10 17-Sep-23

Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued Seeking Alpha07:03 17-Sep-23

Johnson & Johnson replaces signature logo in brand revamp The National08:13 16-Sep-23

Here's why Johnson and Johnson just ditched one of the world's oldest logos Creative Bloq02:09 16-Sep-23

Johnson & Johnson Unveils New Logo After 135 Years Bernama00:37 16-Sep-23

Johnson & Johnson faces investigation in South Africa for drug pricing Anadolu Agency21:29 15-Sep-23

STAT Plus: South Africa investigates Johnson & Johnson over ‘excessive pricing’ for its TB drug STAT17:39 15-Sep-23

Johnson & Johnson Is Changing Its Iconic Logo For the First Time in History Entrepreneur Magazine15:16 15-Sep-23

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell? Entrepreneur Magazine11:08 15-Sep-23

South Africa discloses Johnson & Johnson probe following press scrutiny Global Competition Review10:33 15-Sep-23

The Daily Scoop: Johnson & Johnson plays it safe with new logo change PR Daily10:23 15-Sep-23

This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business Fortune09:19 15-Sep-23

Johnson & Johnson under investigation in South Africa over 'excessive' drug prices ABC News08:45 15-Sep-23

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices Mail Online08:33 15-Sep-23

Janssen rebrands its identity European Pharmaceutical Review08:16 15-Sep-23

Covid-19: Drug companies charged South Africa high prices for vaccines, contracts reveal British Medical Journal07:35 15-Sep-23

Johnson & Johnson unleashes power of the ampersand as it follows Sanofi, GSK in major rebrand FiercePharma04:32 15-Sep-23

More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws Bhekisisa02:38 15-Sep-23

Johnson & Johnson Unveils Futuristic Logo: A New Era of Healthcare Innovation YourStory01:22 15-Sep-23

Johnson & Johnson launched a rebranding and adopted a new logo as it focuses on prescription… The Wall Street Journal23:39 14-Sep-23

Johnson & Johnson’s iconic logo is getting scrapped, replaced with a more modern look NJ.com - The Jersey Journal21:39 14-Sep-23

P&G, J&J Sold Useless Decongestants, Suit Says Law36020:47 14-Sep-23

Johnson & Johnson cuts Tampa office space by 60% in Westshore move Tampa Bay Business Journal18:23 14-Sep-23

American Company Says It’s Tossing Iconic 136-Year-Old Logo, One Of The Oldest In The World The Daily Caller17:52 14-Sep-23

Johnson & Johnson to Unveil New Logo After 136 Years NewsMax17:19 14-Sep-23

Johnson & Johnson ditching script logo after 130 years Fox News16:27 14-Sep-23

Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations Benzinga15:16 14-Sep-23

Johnson & Johnson updates logo for first time in over 135 years PennLive.com, Pennsylvania15:13 14-Sep-23

DiCello Levitt: Pharmaceutical Companies Violated Consumer Protection Laws, Committed Fraud by… Business Wire (Press Release)14:48 14-Sep-23

view more headlines

3 Oct 05:43

Johnson & Johnson News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Johnson & Johnson news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as Johnson & Johnson news might appear - please feel free to contact us regarding any persistent issues.

Johnson & Johnson

Latest News

Johnson & Johnson News

Business Top Stories